Bio-Rad Labs (BIO) Tops Q2 EPS by 37c
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $281.11 -0.47%
Revenue Growth %: -4.3%
Financial Fact:
Weighted average common shares - basic: 29.4M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: -4.3%
Financial Fact:
Weighted average common shares - basic: 29.4M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q2 EPS of $1.64, $0.37 better than the analyst estimate of $1.27. Revenue for the quarter came in at $575.9 million versus the consensus estimate of $548.43 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Wintermar acquires full control of Fast Offshore Supply, adding 5 new CTVs
- Ridgepost Capital acquires Stellus Capital Management for $4B AUM
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
